drugset / Trial / NCT00608959

Study of Antimicrobial Activity of Omiganan 1% Gel vs. Chlorhexidine 2% for Topical Skin Antisepsis in Healthy Adult Subjects

NCT00608959

Phase 3 Completed 30 enrolled Cadence Pharmaceuticals
Non-randomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this research study is to determine if omiganan 1% gel (the investigational medication in this research study) is effective and safe when compared to chlorhexidine 2% (an FDA approved medication) for killing bacteria (germs) that live on the surface of the skin. Both of the study medications are applied topically (on the surface of the skin).

Timeline

Start
2008-05
Primary completion
2008-06
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Chlorhexidine Small molecule 2 % Topical
Subject Omiganan Protein / enzyme biologic 1 % Topical

Indications